Favaretto AG - Search Results

1

Second and third line treatment in advanced non-small cell lung cancer.

Favaretto AG, Pasello G, Magro C. Favaretto AG, et al. Discov Med. 2009 Dec;8(43):204-9. Discov Med. 2009. PMID: 20040271 Free article.

2

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.

Paccagnella A, Favaretto A, Brandes A, Ghiotto C, Fornasiero A, Volpi A, Pappagallo G, Festi G, Cipriani A, Vinante O, et al. Paccagnella A, et al. Cancer. 1990 Jun 15;65(12):2631-4. doi: 10.1002/1097-0142(19900615)65:12<2631::aid-cncr2820651205>3.0.co;2-y. Cancer. 1990. PMID: 2160312 Clinical Trial.

3

Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.

Paccagnella A, Favaretto A, Oniga F, Festi G, Lauro S, Morabito A, Ossana L, Sartore F, DePoli F, Fiorentino MV. Paccagnella A, et al. Cancer. 1996 Oct 15;78(8):1701-7. Cancer. 1996. PMID: 8859183 Clinical Trial.

4

Paclitaxel and carboplatin: a phase I study in advanced non-small cell lung cancer.

Paccagnella A, Favaretto A, Oniga F, Ossana L. Paccagnella A, et al. Semin Oncol. 1996 Dec;23(6 Suppl 16):76-9. Semin Oncol. 1996. PMID: 9007128 Clinical Trial.

5

Pre-operative chemoradiotherapy in non-small cell lung cancer stage III patients. Feasibility, toxicity and long-term results of a phase II study.

Favaretto A, Paccagnella A, Tomio L, Sartori F, Cipriani A, Zuin R, Reffosco L, Calabro F, Rea F, Ghiotto C, Chiarion-Sileni V, Oniga F, Loreggian L, Fiorentino MV. Favaretto A, et al. Eur J Cancer. 1996 Nov;32A(12):2064-9. doi: 10.1016/s0959-8049(96)00248-1. Eur J Cancer. 1996. PMID: 9014746 Clinical Trial.

6

The role of surgery in integrated therapies for non-small-cell lung cancer.

Sartori F, Bortolotti L, Michelon M, Colaut F, Loy M, Rea F, Favaretto A. Sartori F, et al. Ann Oncol. 1999;10 Suppl 5:S73-6. doi: 10.1093/annonc/10.suppl_5.s73. Ann Oncol. 1999. PMID: 10582144 Free article. Review.

7

Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).

Favaretto A, Ceresoli GL, Paccagnella A, Barbieri F, Bearz A, Ghiotto C, Oniga F, Schiavon S, Frustaci S, Villa E. Favaretto A, et al. Ann Oncol. 2000 Nov;11(11):1421-6. doi: 10.1023/a:1026527004596. Ann Oncol. 2000. PMID: 11142482 Free article. Clinical Trial.

8

Overview on ongoing or planned clinical trials in Europe.

Favaretto A. Favaretto A. Lung Cancer. 2005 Jul;49 Suppl 1:S117-21. doi: 10.1016/j.lungcan.2005.03.022. Epub 2005 Apr 9. Lung Cancer. 2005. PMID: 15950791 Review.

9

Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.

Paccagnella A, Oniga F, Bearz A, Favaretto A, Clerici M, Barbieri F, Riccardi A, Chella A, Tirelli U, Ceresoli G, Tumolo S, Ridolfi R, Biason R, Nicoletto MO, Belloni P, Veglia F, Ghi MG. Paccagnella A, et al. J Clin Oncol. 2006 Feb 1;24(4):681-7. doi: 10.1200/JCO.2005.03.2722. J Clin Oncol. 2006. PMID: 16446341 Clinical Trial.

10

Overprotective caregivers of elderly cancer patients: a case report.

Basso U, Brunello A, Magro C, Favaretto A, Monfardini S. Basso U, et al. Tumori. 2006 Jul-Aug;92(4):362-3. Tumori. 2006. PMID: 17036533

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

117 results

Search Page

Filters